Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05759572
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-02-26
Brief Title:
Apatinib With CDK46 Inhibitor and Endocrine Therapy in HR HER2- Advanced Breast Cancer
Sponsor:
Fudan University
Organization:
Fudan University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer Metastatic |
Keywords:
| Name | View |
|---|---|
| first-line therapy | View |